Health Care Practice Leader Douglas Grimm was quoted on the growing interest among employers in direct primary care models and the financial predictability these models offer compared to traditional insurance.
Chairman Anthony Lupo and Fashion Group Co-Leader Michelle Mancino Marsh discussed the complexities and intellectual property (IP) concerns arising from the expansion of artificial intelligence (AI) in the fashion and retail industry. “AI will be a sea change not just for the fashion industry but for society as a whole,” Tony said.
Health Care Industry Group Co-Leader Annie Chang Lee was quoted on how hospitals and health care workers are vulnerable to potential raids by US Immigration and Customs Enforcement (ICE) following changes to federal policy regarding enforcement in sensitive locations.
Partner Kevin M. Nelson was quoted on the feasibility of the US Department of Commerce’s unprecedented use of “march-in” rights under the Bayh-Dole Act to request a list of patents owned by Harvard University that used government funds to support the underlying research.
Partner Ehsun Forghany was interviewed by Bloomberg Law about the new discretionary denial procedure implemented by US Patent and Trademark Office’s (USPTO) acting director, Coke Stewart, and how this policy shift has created uncertainty for both petitioners and patent owners in post-grant proceedings before the Patent Trial and Appeal Board (PTAB).
Customs & Import Compliance Practice Group Leader Angela Santos was quoted in a recent New York Times article discussing the swift actions taken by businesses to remove goods from “bonded warehouses” in response to the latest tariff threats from the Trump Administration.
Partner Marylee Jenkins, former US Patent and Trademark Office Patent Public Advisory Committee (PPAC) chairperson, was quoted by The Wall Street Journal on the discussion from the US Department of Commerce on charging patent holders 1% to 5% of their overall patent value.
Partner Emily Cowley Leongini was quoted on Sarepta Therapeutics’ decision to pause sales of its Duchenne muscular dystrophy gene therapy Elevidys (delandistrogene moxeparvovec) following a request from the US Food and Drug Administration (FDA).
Partner Ehsun Forghany was interviewed by Law360 about the US Patent and Trademark Office’s (USPTO) upcoming launch of DesignVision — an artificial intelligence (AI)-powered tool for conducting image-based prior art searches for design patents.
D. Jacques Smith, Michelle J. Shapiro, Rebekkah R.N. Stoeckler, Stephanie Trunk, Nadia Patel, Pascal Naples
The government has announced a renewed and expanded focus on False Claims Act enforcement, doubling down on traditional healthcare priorities like kickbacks and drug pricing while signaling increased scrutiny of electronic health records manipulation, a shift that could expose data vendors and other nontraditional healthcare entities to scrutiny from the US Department of Justice and the US Department of Health and Human Services.
Investigations Practice Group Leader D. Jacques Smith and Health Care Industry Co-Leader Nadia Patel were quoted on the recent increase in health care enforcement actions under the False Claims Act (FCA), as it remains a top priority for the US Department of Justice (DOJ).
In Law360’s 2025 midyear report, Partner Danielle Bulger was quoted on recent, pivotal copyright rulings by US district courts, including regarding implications of the affirmative defense of fair use in the context of AI model training, and copyright litigation strategy.
FDA Practice Group Leader Karen Carr was featured on The International Fresh Produce Association’s (IFPA) podcast, Fresh Takes on Tech, in its recent episode “Science and Policy: The Battle Shaping Ag Biotechnology.”
Partner J. Michael Showalter discussed the growing impact of artificial intelligence (AI)- driven data centers on energy demand and emissions.
Partner Ehsun Forghany was interviewed by Law360 on the rise of patent case filings, particularly in the Eastern District of Texas, which, after receiving 1,069 new patent complaints in 2024, surpassed the Western District of Texas as the most popular venue for patent litigation.
Gayland Hethcoat was quoted on a federal judge’s order to remove the confidentiality designation from hundreds of hours of recordings of presentations and panel discussions that were produced in discovery by the World Professional Association for Transgender Health (WPATH), which is often cited by expert witnesses in cases regarding gender-affirming care.
Customs & Import Compliance Practice Group Leader Angela Santos was quoted on the Trump Administration’s alternative pathways for imposing tariffs. After the Court of International Trade and District Court for the District of Columbia put a halt to Trump’s tariffs, Administration officials say that the president is considering using other tools at his disposal to advance his trade policies.
Partner Antonio Rivera was quoted on the federal court decision that President Trump exceeded his authority when he used the 1977 International Emergency Economic Powers Act (IEEPA) to impose worldwide tariffs by declaring a national emergency based on trade deficits.
Partner Ehsun Forghany was quoted by CosmeticsDesign USA on how industry stakeholders should revisit and revise their intellectual property (IP) strategies after the May 2 closure of the de minimis loophole.
Partner J. Michael Showalter was quoted on the Trump Administration’s lawsuits testing the judiciary’s stance on federal interests in state affairs, particularly concerning state-led climate change initiatives.
Partner Douglas Grimm was quoted on the US Supreme Court’s ruling Loper Bright Enterprises v. Raimondo, marking one year since the landmark decision that ended judicial deference to agency rulemaking.
Chairman Anthony Lupo and Consumer Products Group Co-Leader Michelle Mancino Marsh were quoted on how attorneys play a pivotal role behind the scenes at the Met Gala, one of the world’s premier fashion events.
Partner Jay Halpern was quoted on how restaurants and suppliers are navigating the impact of tariffs on essential supplies.
Customs & Import Compliance Practice Leader Angela Santos was quoted on how importers are strategizing to lessen their liability under the Trump Administration’s tariffs.
Gayland Hethcoat was quoted on the potential for increased data privacy litigation targeting health plans, with the Blue Shield case possibly sparking a “broader wave” of lawsuits.